Atlas Trials

Relative Bioavailability and Bioequivalence of Opicapone

Clinical trial NCT03820037 · COMPLETED

Trial details

NCT number
NCT03820037
Sponsor
Bial - Portela C S.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson Disease
Start date
2019-03-19
Primary completion
2019-06-09
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.